About Instem
Instem is a Healthcare company based in Conshohocken (United States) founded in 1969, and was acquired by ARCHIMED in August 2023. Software for life science data collection and analysis is provided. It operates in the Healthcare and Technology sectors. The company has 177 employees. Instem has completed 10 acquisitions, including BioWisdom, Leadscope and Notocord. Its website instem.com draws about 16 thousand monthly visits. Its Indian entity Instem India Private Limited reported revenue of ₹40.13 Cr. Its focus areas include HealthTech, Life Sciences Tech, Diversified and Life Sciences. Its competitors include Veeva Systems, Strateos and SignalPath; 3 of its 3 listed competitors have raised funding.
Company details
Software solutions for data collection, management, and analysis for the life science industry. It focuses on study workflow automation. It also has a data integration platform that allows integration of databases with bioinformatics analysis tools which makes it possible to integrate proprietary data with publicly available or licensed data. The Knowledge Scan provides an informatics-based service for investigating safety concerns in drug development.
- Headquarters Conshohocken, United States
- Employees 177
- Stage Acquired
- SectorsHealthcareTechnology
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Website instem.com
- Social LinkedIn X
- Acquired by ARCHIMED (Aug 2023)
- Legal Name Instem India Private Limited
- Date of Incorporation 07 Jun, 2012
- Jurisdiction Pune, Maharashtra, India
- Indian entity revenue₹40.13 Cr
FY 2024 · +31% YoY
- Indian entity net profit₹4.57 Cr
FY 2024 · 11% margin
- Indian entity EBITDA₹6.36 Cr
FY 2024 · 16% margin
- InvestorsEuropean Union
& 1 more
- Employee Count177
- Investments & AcquisitionsBioWisdom
& 9 more
- Acquired byARCHIMED
(Aug 2023)
Associated legal entities of Instem
Instem operates through Instem India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Instem India Private Limited CIN U73100PN2012FTC146152 | Active | 07 Jun 2012 | Pune, Maharashtra | ₹40.1 Cr | 177 | 2 | View details |
Funding Insights of Instem
- Total Rounds 4
- First Round $7.25M
(Feb 2016)
- Investors Count 1
All 4 funding rounds of Instem with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2022 | Grant | – | – | ||
| Jun 2020 | $19.56M | Post-IPO | – | – | – |
| Jan 2020 | $30,830 | Grant | – | – | |
| Feb 2016 | $7.25M | Post-IPO | – | – | – |
2 investors in total: 2 institutional.
Investors in Instem
Instem has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and ARCHIMED.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare industries are funded and supported globally by ARCHIMED. | archimed.group | Lyon, France | ||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Instem
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Instem India Private Limited (Instem)
Instem India Private Limited is the primary company behind Instem. The board of Instem India Private Limited currently have 2 directors; the longest-serving is Philip John Reason, appointed in 2012. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Philip John Reason DIN 05223319 | Director | 07 Jun 2012 | 14 yrs 5 mo | Instem India Private Limited |
| Milind Prabhakar Bargaje DIN 06712767 | Director | 18 Oct 2013 | 13 yrs | Instem India Private Limited |
People of Instem
109 people are tracked at Instem (22 in leadership, 87 in team); the tracked headcount is 177.
| Name | Role | Group |
|---|---|---|
Phil Reason | Chief Executive Officer | Leadership |
Nigel Goldsmith | Chief Financial Officer | Leadership |
Martin T. | Director Of Global Support | Leadership |
Lily Zhang | General Manager - China | Leadership |
Aaron Brooks | Head Of Customer Experience | Leadership |
Eve Leconte | Chief Administrative Officer | Leadership |
Marybeth Thompson | Chief Operating Officer | Leadership |
Louis Brook | Chief Technology Officer | Leadership |
Fcca Natalja Ritchie | Head Of Financial Reporting | Leadership |
Jayleen Lehrke | Global People & Culture Director | Leadership |
Wendy Sharratt | Head Of Group Taxes | Leadership |
Marcus Plating | Director Project Management Office | Leadership |
Clayton Leonard | Senior Director, Project Management Office | Leadership |
Jl Alarcon (John) | Vp, Finance & Strategic Partnerships | Leadership |
Pete Dugan | Study Management, Account Director | Leadership |
Iain Graham | Director Of Client Implementation Services | Leadership |
Georgina Brookhouse | Head Of Software Testing | Leadership |
Stephen Baker | Senior Vice President, Clinical Trial Acceleration | Leadership |
Philip Loucks | Director, Commercial - Instem Clinical | Leadership |
Rachel Harper | Vice President, Global Service Delivery | Leadership |
89 more people are available in the full profile.
Complete people profiles for Instem
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Instem
Figures of Instem India Private Limited, the primary company behind Instem, for FY 2024. Revenue was ₹40.13 Cr (+31% year on year). Net profit was ₹4.57 Cr (11% margin). EBITDA was ₹6.36 Cr (16% margin). Revenue has grown at a compounded annual rate of +170% over three years and +27% over five years.
- ₹40.13 CrRevenue · FY 2024 · +31% YoY
- ₹4.57 CrNet profit · 11% margin
- ₹6.36 CrEBITDA · 16% margin
- ₹10 LakhPaid-up capital
- 177Employees (provident fund records)
- +170%Revenue CAGR, 3 years
- +27%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Instem India Private Limited are on its company page.
Detailed financial statements for Instem
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Instem
Instem has strategically engaged in corporate development activities, having acquired 10 companies. Notable acquisitions include BioWisdom, Leadscope and Notocord.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Cloud-based unified GRC software is provided for regulated industries. | xybion.com | Princeton, United States | 1977 | Jul 2025 | •••• | |
Cloud-based laboratory information and data management tools are provided. | rockstepsolutions.com | Portland, United States | 2013 | Jul 2025 | •••• | |
AI-based LIMS tools are provided for life sciences providers. | pdslifesciences.com | Basel, Switzerland | 1980 | Sep 2021 | $15.55M | |
Data and process optimization services for Life Sciences & Healthcare companies | d-wise.com | Morrisville, United States | 2003 | Mar 2021 | $31M | |
Software solutions and services to the pharmaceutical and biotechnology industry | edge-ka.com | Guildford, United Kingdom | 2005 | Mar 2021 | $11.83M | |
Chemical toxicity assessment software and databases are provided. | leadscope.com | Columbus, United States | 1998 | Nov 2019 | $4.6M | |
Life sciences software publisher | notocord.com | 1989 | Sep 2016 | $4.68M | ||
Software solutions are provided for life sciences and other sectors. | samarindrms.com | Deeside, United Kingdom | 1987 | May 2016 | $3.65M | |
Software solutions for genetic toxicology assays are developed. | perceptive.co.uk | Bury St Edmunds, United Kingdom | 1990 | Nov 2013 | $2.09M | |
Software tools for the acquisition, integration, visualization and high-value analysis of healthcare intelligence | biowisdom.com | Cambridge, United Kingdom | 2000 | Mar 2011 | $1.46M |
Complete acquisition details for Instem
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Instem
15 dated milestones of Instem across 56 years, from founding to its latest funding, stage changes and deals.
- Founded Instem is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires BioWisdom.
- Acquisition Acquires Perceptive Instruments.
- Funding First funding round of $7.2M.
- Acquisition Acquires Samarind.
- Acquisition Acquires Notocord.
- Acquisition Acquires Leadscope.
- Acquisition Acquires The Edge Software Consultancy.
- Acquisition Acquires d-Wise.
- Acquisition Acquires PDS Life Sciences.
- Funding Latest funding round, Grant,.
- Exit Acquired by ARCHIMED.
- Acquisition Acquires RockStep Solutions.
- Acquisition Acquires Xybion.
Competitors of Instem
Instem has 3 listed competitors in our database, 3 of them funded. They include Veeva Systems, Strateos and SignalPath.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| veeva.com | 2007 | Pleasanton, United States | $4M | 226 | Cloud-based data management solutions for healthcare are provided. | |
| strateos.com | 2019 | Menlo Park, United States | $72.6M | 147 | Provider of cloud based platform provides data driven information for biotech research | |
| signalpath.com | 2014 | Durham, United States | $35.64M | Cloud-based software solutions for clinical research sites are provided. |
Detailed competitors of Instem
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Instem
The website of Instem (instem.com) receives about 16K visits a month and ranks #1,657,385 among all websites worldwide, #2,227 in Biotechnology and Pharmaceuticals.
- Monthly visits16K
▲ 12.2% vs previous month
- Unique visitors5.9K
per month
- Global rank#1,657,385
among all websites
- Category rank#2,227
Health · Biotechnology and Pharmaceuticals
- Bounce rate40%
- Pages per visit2.0
- Average visit25 sec
- DevicesDesktop 34% · Mobile 66%
Websites whose visitors overlap most with Instem. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| patientsafesolutions.com | 45% | View details |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Instem (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Instem
Complete news archive for Instem
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Instem
Instem was founded in 1969 and raised its 1st funding round 47 years after it was founded.
Instem is headquartered in Conshohocken, United States. It is registered at Conshohocken, Pennsylvania, United States.
Instem has 177 employees.
The primary company behind Instem, Instem India Private Limited, reported revenue of ₹40.13 Cr for FY 2024, up 31% year on year.
Software solutions for data collection, management, and analysis for the life science industry. It focuses on study workflow automation. It also has a data integration platform that allows integration of databases with bioinformatics analysis tools which makes it possible to integrate proprietary data with publicly available or licensed data. The Knowledge Scan provides an informatics-based service for investigating safety concerns in drug development.
Instem's top competitors include Veeva Systems, Strateos and SignalPath.
Instem has 2 investors. Key investors include European Union, and ARCHIMED.
Instem operates through Instem India Private Limited.
Yes. Instem was acquired by ARCHIMED in August 2023.
The legal entities of Instem currently have 2 directors, including Milind Prabhakar Bargaje, Philip John Reason.